News

Moderna outlines $1.4B-$1.7B cost reductions by 2027 while advancing oncology pipeline
Q1 2025 Management View CEO Stephane Bancel highlighted that Q1 revenues were $0.1 billion, with a net loss of $1 billion, ...
Stocktwits on MSN37m
Moderna Reports Q1 Revenue Drop, Warns Of Delay In Covid/Flu Vaccine Approval: Retail Sentiment Sours
Shares of Moderna, Inc. (MRNA) traded over 6% lower on Thursday morning after the company reported a decline in first-quarter ...